EU clears vaccine sites to boost inoculation drive




  • In US
  • 2021-03-26 13:28:07Z
  • By Reuters

By Philip Blenkinsop and Joan Faus

BRUSSELS/BARCELONA (Reuters) - The European Medicines Agency approved on Friday two factories for the production of COVID-19 vaccines, with the European Union banking on them to boost deliveries in the second quarter and accelerate the slow pace of inoculations in the bloc.

The EMA said in statement it had cleared the Halix production site in the Netherlands that makes the AstraZeneca vaccine and a facility in Marburg in Germany producing BioNTech/Pfizer shots.

The European Union has blamed massive shortfalls of AstraZeneca doses for the slow roll-out of vaccines across the bloc, while BioNTech/Pfizer has plans to sharply increase its deliveries in the second quarter.

European Internal Markets Commissioner Thierry Breton said vaccines produced by AstraZeneca within the bloc would stay there until the company returns to fulfilling its delivery commitments.

His comments echoed those of Commission President Ursula von der Leyen after a video conference summit of EU leaders on Thursday. Of 300 million doses due to be delivered to EU countries by the end of June, AstraZeneca aims to deliver only 100 million.

AstraZeneca's request to the EMA for authorisation of its Dutch plant run by subcontractor Halix was only confirmed on Wednesday by EU Health Commissioner Stella Kyriakides.

It is not clear why the request only came now despite Halix being listed as a supplier in the company's contract with the European Union in August. AstraZeneca has declined to comment on the timing, but said Halix is a relatively small part of its vaccine supply chain. Halix says its monthly production is about 5 million doses.

Kyriakides said she expected vaccines from this plant to be delivered to EU countries in the coming days as part of AstraZeneca's commitment to EU citizens.

It is also unclear whether the approval of Halix will allow the distribution of 16 million doses of AstraZeneca vaccines seized this week by the Italian authorities, and which AstraZeneca said were waiting approval before being shipped to EU countries. AstraZeneca declined to comment on this.

If the doses seized in Italy were manufactured at Halix, as European Union sources had suspected, the green light for the site would mean the batch is cleared for use.

Under an AstraZeneca internal schedule dated March 10 and seen by Reuters, the company expected to deliver to the EU nearly 10 million doses of vaccines next week, a third of its entire supply to the EU so far.

The supply forecast hinged on the approval of the Halix site, the document said.

MAJOR PFIZER-BIONTECH RAMP-UP

The EU's drugs regulator also granted German biotech firm BioNTech approval for the use of COVID-19 vaccines produced at its new site in Marburg.

BioNTech launched production in February at the site, which it purchased from Novartis last year.

BioNTech said on Friday the Marburg site had an annual capacity of 1 billion doses, up from 750 million doses flagged previously.

That makes it a key element of BioNTech and partner Pfizer's global delivery plans of 2.3 billion to 2.4 billion doses this year.

The first batches of vaccines manufactured at the Marburg site are expected to be delivered in the second half of April.

Kyriakides called the approval "very good news" that should enable the expected acceleration of production and deliveries.

(Reporting by Philip Blenkinsop and Francesco Guarascio in Brussels, Ludwig Burger in Frankfurt; Editing by Jon Boyle and Giles Elgood)

COMMENTS

More Related News

When will we reach herd immunity? As COVID-19 variants multiply, the race has become
When will we reach herd immunity? As COVID-19 variants multiply, the race has become 'a little harder'

BALTIMORE - Imagine a race where not only is your opponent finding ways to run faster, but hurdles pop up unpredictably and the finish line keeps moving...

To Speed Vaccination, Some Call for Delaying Second Shots
To Speed Vaccination, Some Call for Delaying Second Shots

The prospect of a fourth wave of the coronavirus, with new cases climbing sharply in the Upper Midwest, has reignited a debate among vaccine experts over how...

More Black Americans open to vaccines after outreach efforts
More Black Americans open to vaccines after outreach efforts
  • World
  • 2021-04-10 13:47:39Z

Like others in her family, Mattie Pringle had doubts about taking the coronavirus vaccine. The 57-year-old Black woman from Myrtle Beach, South Carolina...

EU
EU's Michel says COVID-19 recovery fund is sufficient - Les Echos

The European Union's COVID-19 recovery response is robust and does not fall short when compared with the United States' $1.9 trillion recovery plan, European...

Stalled at first jab: Vaccine shortages hit poor countries
Stalled at first jab: Vaccine shortages hit poor countries
  • World
  • 2021-04-10 06:20:30Z

As many as 60 countries, including some of the world's poorest, might be stalled at the first shots of their coronavirus vaccinations because nearly all...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US